Cardiotoxicity in Breast Cancer Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Cardiotoxicity in Breast Cancer Patients — Stella

Home/Breast Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Egypt

Al demerdash hospital at oncology departement, Cairo, Cairo Governorate

Key details

Phase

Post-approval study

Sponsor

Helwan University

Enrollment target

~40 participants

Started

September 2024

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 60 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.